SLC12A3 - solute carrier family 12 member 3 Gene
Also Known as NCC; TSC; NCCT
Species: Homo sapiens
About SLC12A3
This gene has 6 transcripts (splice variants), 203 orthologues, 8 paralogues and is associated with 2 phenotypes. Restricted expression toward kidney (RPKM 65.2).
Summary
This gene encodes a renal thiazide-sensitive sodium-chloride cotransporter that is important for electrolyte homeostasis. This cotransporter mediates sodium and chloride reabsorption in the distal convoluted tubule. Mutations in this gene cause Gitelman syndrome, a disease similar to Bartter's syndrome, that is characterized by hypokalemic alkalosis combined with hypomagnesemia, low urinary calcium, and increased Renin activity associated with normal blood pressure. This cotransporter is the target for thiazide diuretics that are used for treating high blood pressure. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
SLC12A3 Products (4)
| mRNA | Protein | Name |
|---|---|---|
| NM_000339.3 | NP_000330.3 | solute carrier family 12 member 3 isoform 1 |
| NM_001126107.2 | NP_001119579.2 | solute carrier family 12 member 3 isoform 2 |
| NM_001126108.2 | NP_001119580.2 | solute carrier family 12 member 3 isoform 3 |
| NM_001410896.1 | NP_001397825.1 | solute carrier family 12 member 3 isoform 4 |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
22406640 | GOA |
| enables sodium:chloride symporter activity |
IDA
IDA: Inferred from direct assay
|
18270262 | GOA |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| involved in renal sodium ion absorption |
IDA
IDA: Inferred from direct assay
|
18270262 | GOA |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| located in apical plasma membrane |
IDA
IDA: Inferred from direct assay
|
21397062 | GOA |
| located in extracellular exosome |
IDA
IDA: Inferred from direct assay
|
21082674 | GOA |
| is active in plasma membrane |
IDA
IDA: Inferred from direct assay
|
22009145 | GOA |
SLC12A3 Protein Structure
AA_permease_N: Amino acid permease N-terminal (46 - 112)
AA_permease: Amino acid permease (141 - 646)
- 0
- 200
- 400
- 600
- 800
- 1021 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
solute carrier family 12 member 3 |
|
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Gitelman Syndrome |
|
|
| Hypokalemia |
|
|
| Bartter Disease |
|
|
| Chondrocalcinosis |
|
|
| Bartter Syndrome, Type 3 |
|
|
| Renal Tubular Transport Disease |
|
|
| Arthrogryposis, Distal, Type 3 |
|
|
| Pseudohypoaldosteronism |
|
|
| Conn'S Syndrome |
|
|
| Nephrocalcinosis |
|
|
| Seizures, Sensorineural Deafness, Ataxia, Mental Retardation, And Electrolyte Imbalance |
|
|
| Bartter Syndrome, Type 1, Antenatal |
|
|
| Pendred Syndrome |
|
|
| Hypertension, Essential |
|
|
| Mineral Metabolism Disease |
|
|
| Dipsogenic Diabetes Insipidus |
|
|
| Thyroid Dyshormonogenesis 6 |
|
|
| Kidney Disease |
|
|
| Agenesis Of The Corpus Callosum With Peripheral Neuropathy |
|
|
| Familial Periodic Paralysis |
|
|
| Hypokalemic Periodic Paralysis, Type 1 |
|
|
| Apparent Mineralocorticoid Excess |
|
|
| Liddle Syndrome 1 |
|
|
| Hypomagnesemia 3, Renal |
|
|
| Miliaria Rubra |
|
|
| Renal Tubular Acidosis |
|
|
| Miliaria |
|
|
| Nephrogenic Diabetes Insipidus |
|
|
| Adrenal Gland Disease |
|
|
| Osteoporosis |
|
|
| Polyhydramnios |
|
|
| Distal Arthrogryposis |
|
|
| Cakut |
|
|
| Autosomal Dominant Polycystic Kidney Disease |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Rattus norvegicus | SLC12A3 | RGD | RGD:3686 |
| Felis catus | SLC12A3 | VGNC | VGNC:65189 |
| Mus musculus | SLC12A3 | MGD | MGI:108114 |
| Bos taurus | SLC12A3 | VGNC | VGNC:34666 |
| Macaca mulatta | SLC12A3 | VGNC | VGNC:77387 |
| Canis familiaris | SLC12A3 | VGNC | VGNC:46220 |
| Others | SLC12A3 | NCBI |